chr4-163854081-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001394959.1(MARCHF1):c.51C>A(p.Asn17Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000138 in 1,536,886 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001394959.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MARCHF1 | NM_001394959.1 | c.51C>A | p.Asn17Lys | missense_variant | 4/10 | ENST00000514618.6 | NP_001381888.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MARCHF1 | ENST00000514618.6 | c.51C>A | p.Asn17Lys | missense_variant | 4/10 | 5 | NM_001394959.1 | ENSP00000421322.1 |
Frequencies
GnomAD3 genomes AF: 0.0000592 AC: 9AN: 152136Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000208 AC: 3AN: 144470Hom.: 0 AF XY: 0.0000130 AC XY: 1AN XY: 77112
GnomAD4 exome AF: 0.000147 AC: 203AN: 1384632Hom.: 0 Cov.: 30 AF XY: 0.000136 AC XY: 93AN XY: 683258
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152254Hom.: 0 Cov.: 33 AF XY: 0.0000806 AC XY: 6AN XY: 74460
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 15, 2024 | The c.51C>A (p.N17K) alteration is located in exon 3 (coding exon 1) of the MARCH1 gene. This alteration results from a C to A substitution at nucleotide position 51, causing the asparagine (N) at amino acid position 17 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at